MAUDE’S AWARDS 2026 RECIPIENTS   ...

Listen to or Subscribe...

#Alzheimer s and #Heart...

Researchers at Edith Cowan University’s (ECU) Centre for Precision Health have made a...

Hepatitis B Breakthrough: GSK's...

The US FDA has approved GSK's Hibsago for chronic hepatitis...

GSM, Ounces and What...

A hoodie’s weight is the weight of its fabric, usually listed as...
HomeVIDEOS【Multi Sub】Good Killer...

【Multi Sub】Good Killer | FULL | iQIYI Anime Asia



Welcome to subscribe to【iQIYI Asia Anime】💥 Embark on your thrilling anime journey!
🔥 Weekly updates of China’s top fantasy masterpieces 🔥
All the amazing anime you want to watch are right here:
👉
Thank you for your support!

【Synopsis】
Goode was once a core member of the mysterious organization ARGUS, but now he’s shed its shadow and, along with his naive and innocent sidekick Sura, makes a living by taking on various commissions for a living. The two always seem to get thankless jobs—one minute they’re outwitting aliens, the next they’re racing bicycles with a shaving maniac… And Goode’s two troublemakers—a PhD student skilled in all sorts of useless inventions and a vain, arrogant guy—always seem to get in the way, making things even more chaotic.

Nevertheless, “Trouble Killer” Goode, along with three other oddballs, spared no effort in completing one commission after another, helping many people in distress.
#iQIYIOriginal #Demon‘sascension

📢 For more exciting content, follow us:
iQIYI Anime:
iQIYI อะนิเมะ Thai:

source

Continue reading

MAUDE’S AWARDS 2026 RECIPIENTS    – Alzheimer’s Speaks

Listen to or Subscribe to the Alzheimer’s Speaks Podcast on Apple MAUDE’S AWARDS 2026 RECIPIENTS    Lori La Bey talks with Maude’s Awards, which was developed in 2019 to gather and share...

#Alzheimer s and #Heart Disease

Researchers at Edith Cowan University’s (ECU) Centre for Precision Health have made a groundbreaking discovery, revealing a significant genetic connection between Alzheimer’s disease (AD) and several coronary artery disease (CAD) related disorders. This research may offer new opportunities to...

Hepatitis B Breakthrough: GSK's New Drug Hibsago Helped 19% Stay Off Treatment

The US FDA has approved GSK's Hibsago for chronic hepatitis B, with 19% of trial participants achieving a functional cure.